Correlation Between Day One and Indaptus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Day One and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Indaptus Therapeutics, you can compare the effects of market volatilities on Day One and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Indaptus Therapeutics.
Diversification Opportunities for Day One and Indaptus Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Day and Indaptus is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Day One i.e., Day One and Indaptus Therapeutics go up and down completely randomly.
Pair Corralation between Day One and Indaptus Therapeutics
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Indaptus Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.31 times less risky than Indaptus Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The Indaptus Therapeutics is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 103.00 in Indaptus Therapeutics on December 3, 2024 and sell it today you would lose (25.00) from holding Indaptus Therapeutics or give up 24.27% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Day One Biopharmaceuticals vs. Indaptus Therapeutics
Performance |
Timeline |
Day One Biopharmaceu |
Indaptus Therapeutics |
Day One and Indaptus Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Day One and Indaptus Therapeutics
The main advantage of trading using opposite Day One and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |